Clay B. Siegall
Position
- Co-Founder, President and Chief Executive Officer, Seattle Genetics Inc.
Education
- Ph.D. in Genetics, George Washington University
- B.S. in Zoology, University of Maryland
Experience
- Co-founded Seattle Genetics Inc. in 1998
- Has guided Seattle Genetics Inc.s’ capital-raising activities, securing more than $230 million through public and private financings
- The company has entered into multiple strategic collaborations
- Has worked with the Bristol-Myers Squibb Pharmaceutical Research Institute from 1991 to 1997 and the National Cancer Institute, National Institutes of Health from 1988 to 1991
- Serves on the Board of Directors of Alder BioPharmaceuticals, a private biotechnology company, and the [wabio.com|Washington Biotechnology and Biomedical Association (WBBA)]], as well as on the Board of Governors of the Fred Hutchinson Cancer Research Business Alliance
